Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
Clinical trial NCT04066088 · WITHDRAWN
Trial details
- NCT number
- NCT04066088
- Sponsor
- NYU Langone Health
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-08-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.